help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-0311
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
147/12/5826    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yakar, S.
Right arrow Articles by LeRoith, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yakar, S.
Right arrow Articles by LeRoith, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Nutrition
*Obesity
Endocrinology Vol. 147, No. 12 5826-5834
Copyright © 2006 by The Endocrine Society

Increased Tumor Growth in Mice with Diet-Induced Obesity: Impact of Ovarian Hormones

Shoshana Yakar1, Nomeli P. Nunez1, Patricia Pennisi, Pnina Brodt, Hui Sun, Lucia Fallavollita, Hong Zhao, Louis Scavo, Ruslan Novosyadlyy, Naamit Kurshan, Bethel Stannard, Joyce East-Palmer, Nicole C. P. Smith, Susan N. Perkins, Robin Fuchs-Young, J. Carl Barrett, Stephen D. Hursting and Derek LeRoith

Diabetes Branch (S.Y., P.P., H.S., H.Z., L.S., B.S., J.E.-P., D.L.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, and Nutrition and Molecular Carcinogenesis Section (N.P.N., N.C.P.S., S.N.P., J.C.B., S.D.H.), Laboratory of Biosystems and Cancer, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892; Department of Medicine and Surgery (P.B., L.F.), McGill University Health Center, Royal Victoria Hospital, Montreal, Quebec, Canada H3A 1A1; Basic Research Program (N.C.P.S.), Science Applications International Corp.-Frederick, Inc., National Cancer Institute Frederick, Frederick, Maryland 21702-1201; and Department of Carcinogenesis (R.F.-Y., S.D.H.), University of Texas-M.D. Anderson Cancer Center, Smithville, Texas 78957

Address all correspondence and requests for reprints to: Shoshana Yakar, Ph.D., Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, New York 10029-6574. E-mail: shoshana.yakar{at}mssm.edu.

Obesity increases the risk of many cancers in both males and females. This study describes a link between obesity, obesity-associated metabolic alterations, and the risk of developing cancer in male and female mice. The goal of this study was to evaluate the relationship between gender and obesity and to determine the role of estrogen status in obese females and its effect on tumor growth. We examined the susceptibility of C57BL/6 mice to diet-induced obesity, insulin resistance/glucose intolerance, and tumors. Mice were injected sc with one of two tumorigenic cell lines, Lewis lung carcinoma, or mouse colon 38-adenocarcinoma. Results show that tumor growth rate was increased in obese mice vs. control mice irrespective of the tumor cell type. To investigate the effect of estrogen status on tumor development in obese females, we compared metabolic parameters and tumor growth in ovariectomized (ovx) and intact obese female mice. Obese ovx female mice developed insulin resistance and glucose intolerance similar to that observed in obese males. Our results demonstrate that body adiposity increased in ovx females irrespective of the diet administered and that tumor growth correlated positively with body adiposity. Overall, these data point to more rapid tumor growth in obese mice and suggest that endogenous sex steroids, together with diet, affect adiposity, insulin sensitivity, and tumor growth in female mice.




This article has been cited by other articles:


Home page
EndocrinologyHome page
H. Nave, G. Mueller, B. Siegmund, R. Jacobs, T. Stroh, U. Schueler, M. Hopfe, P. Behrendt, T. Buchenauer, R. Pabst, et al.
Resistance of Janus Kinase-2 Dependent Leptin Signaling in Natural Killer (NK) Cells: A Novel Mechanism of NK Cell Dysfunction in Diet-Induced Obesity
Endocrinology, July 1, 2008; 149(7): 3370 - 3378.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Miyamoto, Y. Yasui, T. Tanaka, H. Ohigashi, and A. Murakami
Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice
Carcinogenesis, May 1, 2008; 29(5): 1057 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. N Pollak
Insulin, insulin-like growth factors, insulin resistance, and neoplasia
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 820S - 821S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. D. Hursting, N. P. Nunez, L. Varticovski, and C. Vinson
The Obesity-Cancer Link: Lessons Learned from a Fatless Mouse
Cancer Res., March 15, 2007; 67(6): 2391 - 2393.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society